Experimental vaccine shows promise against deadly brain cancer in some patients - NBC News
Experimental vaccine shows promise against deadly brain cancer in some patients NBC News Roswell Park cancer vaccine trial shows longer survival for some glioblastoma patients WGRZ MimiVax’s cancer vaccine fails phase 2 glioblastoma study, but CEO still sees data as ‘inspiring’ Fierce Biotech Vaccine for deadly brain cancer narrowly misses goal in key trial Endpoints News MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma PR Newswire source https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTV85ZlpGWml4OGdGdU9mdGwtZjF4S3VVbXV6ZjE0LXJyNnVVOGpJX0NuMERUM0JvOG4xNDJXMEVnZXkxRk5JcERhd0R2YUF0V00xektMMlpNNFNlTFJBV2U5ODU4eXVZaHlUQU9NcnpiV3BWT3MzaXFOcEJOWWdwQzQ3QmpiRnlwOVNCZFFnSnA5SWJITnNiOXN3d2pXblVmOW5vSE91VFBTakhvbnNDZU8tNkJLODdiZXJn?oc=5